Table 1.
Clinical and laboratory data in patients according AKI diagnosis
| Exposed control group (N = 31) | All patients (N = 46) | P value* | No AKI patients (N = 32) | AKI patients (N = 14) | P value† | |
|---|---|---|---|---|---|---|
| Age (years) | 21.3 ± 1.7 | 21.3 ± 1.7 | 0.645 | 21.5 ± 1.3 | 20.8 ± 1.9 | 0.911 |
| Baseline GFR (mL/min per 1.73 m2) | 104.1 ± 10.2 | 102.6 ± 12.5 | 0.896 | 104.1 ± 13.1 | 99.2 ± 9.8 | 0.769 |
| Hemoglobin (g/dL) | 13.1 ± 1.7 | 11.7 ± 2.4 | 0.011 | 11.5 ± 3.4 | 12.0 ± 0.9 | 0.596 |
| White blood cells (cells/mm3) | 6.3 ± 2.0 | 11.9 ± 2.9 | < 0.001 | 12.2 ± 3.4 | 11.6 ± 2.5 | 0.784 |
| Platelet count (/μL) | 212.6 ± 26.4 | 155.4 ± 39.1 | < 0.001 | 159.3 ± 39.9 | 150.1 ± 40.8 | 0.573 |
| Alanine transaminase (U/L) | 26.2 ± 9.4 | 106.9 ± 50.7 | < 0.001 | 113.9 ± 49.8 | 95.8 ± 55.0 | 0.369 |
| Creatine kinase (U/L) | 72.9 ± 28.1 | 171.4 ± 57.2 | < 0.001 | 104.6 ± 73.9 | 263.6 ± 81.5 | 0.062 |
| hsCRP (mg/L) | 3.9 ± 3.4 | 110.0 ± 30.9 | < 0.001 | 109.0 ± 66.1 | 111.1 ± 58.3 | 0.940 |
| Malondialdehyde | 3.5 ± 1.8 | 9.5 ± 2.7 | < 0.001 | 8.9 ± 2.6 | 10.6 ± 2.6 | 0.081 |
| ICAM-1 (mg/L) | 234.9 ± 24.4 | 483.1 ± 31.7 | < 0.001 | 434.9 ± 35.3 | 576.9 ± 70.4 | 0.034 |
| Syndecan-1 (ng/mL) | 21.2 ± 7.9 | 73.7 ± 15.9 | < 0.001 | 41.5 ± 11.7 | 112.1 ± 45.4 | 0.021 |
| NGAL (ng/mL) | 32.3 ± 9.7 | 139.4 ± 22.2 | < 0.001 | 139.3 ± 22.6 | 139.8 ± 22.0 | 0.952 |
*
Exposed control group versus all patients.
†
No AKI patients versus AKI patients.